Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56426 - 56450 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	NFASC	23114	downregulated	panobinostat results in decreased expression of NFASC mRNA	1q32.1	A21037
Panobinostat	Approved Investigational	NFATC4	4776	downregulated	panobinostat results in decreased expression of NFATC4 mRNA	14q12	A21037
Panobinostat	Approved Investigational	NFE2L2	4780	upregulated	panobinostat results in increased expression of NFE2L2 mRNA	2q31.2	A21037
Panobinostat	Approved Investigational	NFIB	4781	upregulated	panobinostat results in increased expression of NFIB mRNA	9p23-p22.3	A21037
Panobinostat	Approved Investigational	NGEF	25791	upregulated	panobinostat results in increased expression of NGEF mRNA	2q37.1	A21037
Panobinostat	Approved Investigational	NGFR	4804	upregulated	panobinostat results in increased expression of NGFR mRNA	17q21.33	A21037
Panobinostat	Approved Investigational	NIFK-AS1	254128	downregulated	panobinostat results in decreased expression of NIFK-AS1 mRNA	2q14.3	A21037
Panobinostat	Approved Investigational	NIPAL2	79815	upregulated	panobinostat results in increased expression of NIPAL2 mRNA	8q22.2	A21037
Panobinostat	Approved Investigational	NKD1	85407	upregulated	panobinostat results in increased expression of NKD1 mRNA	16q12.1	A21037
Panobinostat	Approved Investigational	NLGN1	22871	downregulated	panobinostat results in decreased expression of NLGN1 mRNA	3q26.31	A21037
Panobinostat	Approved Investigational	NME8	51314	upregulated	panobinostat results in increased expression of NME8 mRNA	7p14.1	A21037
Panobinostat	Approved Investigational	NMI	9111	upregulated	panobinostat results in increased expression of NMI mRNA	2q23.3	A21037
Panobinostat	Approved Investigational	NMNAT2	23057	upregulated	panobinostat results in increased expression of NMNAT2 mRNA	1q25.3	A21037
Panobinostat	Approved Investigational	NOCT	25819	upregulated	panobinostat results in increased expression of NOCT mRNA	4q31.1	A21037
Panobinostat	Approved Investigational	NOG	9241	upregulated	panobinostat results in increased expression of NOG mRNA	17q22	A21037
Panobinostat	Approved Investigational	NOL4	8715	downregulated	panobinostat results in decreased expression of NOL4 mRNA	18q12.1	A21037
Panobinostat	Approved Investigational	NPFFR2	10886	upregulated	panobinostat results in increased expression of NPFFR2 mRNA	4q13.3	A21037
Panobinostat	Approved Investigational	NPNT	255743	upregulated	panobinostat results in increased expression of NPNT mRNA	4q24	A21037
Panobinostat	Approved Investigational	NPR3	4883	upregulated	panobinostat results in increased expression of NPR3 mRNA	5p13.3	A21037
Panobinostat	Approved Investigational	NPY	4852	upregulated	panobinostat results in increased expression of NPY mRNA	7p15.3	A21037
Panobinostat	Approved Investigational	NPY1R	4886	downregulated	panobinostat results in decreased expression of NPY1R mRNA	4q32.2	A21037
Panobinostat	Approved Investigational	NPY2R	4887	downregulated	panobinostat results in decreased expression of NPY2R mRNA	4q32.1	A21037
Panobinostat	Approved Investigational	NQO1	1728	upregulated	panobinostat results in increased expression of NQO1 mRNA	16q22.1	A21037
Panobinostat	Approved Investigational	NQO2	4835	upregulated	panobinostat results in increased expression of NQO2 mRNA	6p25.2	A21037
Panobinostat	Approved Investigational	NR2F1	7025	upregulated	panobinostat results in increased expression of NR2F1 mRNA	5q15	A21037

Displaying entries 56426 - 56450 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability